首页> 外文期刊>Cureus. >Cardiac Biventricular Metastasis From Renal Cell Carcinoma
【24h】

Cardiac Biventricular Metastasis From Renal Cell Carcinoma

机译:来自肾细胞癌的心脏生物前型转移

获取原文
           

摘要

Secondary cardiac tumors are much more common than primary tumors. Cardiac metastases from renal cell carcinoma (RCC) are rare and can present many years after the patient has been disease-free. We report the case of a 64-year-old man who had been treated for recurrent metastatic RCC. He presented with shortness of breath, and TEE (transthoracic echocardiography) revealed new biventricular hypertrophy and small-to-moderate circumferential pericardial effusion. Cardiac magnetic resonance demonstrated multiple lesions in both the ventricular walls, highly suspicious for metastasis. A?tissue biopsy was obtained, which was inconclusive due to the small sample size. The patient's disease progressively worsened, and, subsequently, he died from cardiac and respiratory failure secondary to the underlying advanced metastatic disease. Cardiac metastasis from RCC is rare and has a wide range of presentations.?Metastatic RCC tends to be resistant to chemotherapy and radiotherapy. Systemic therapy (immunotherapy, molecularly targeted agents) and?surgery may have a role in these patients depending on the extent of disease and sites of involvement.
机译:二次心脏肿瘤比原发性肿瘤更常见。来自肾细胞癌(RCC)的心脏转移稀有,并且在患者无病后多年可能存在。我们举报了一名64岁男子的案件,被治疗用于复发转移RCC。他介绍了呼吸急促,T恤(Transthoracic超声心动图)揭示了新的前心肥大和小于适度的周向心包积液。心脏磁共振在心室壁中显示出多个病变,对转移非常可疑。 a?获得组织活检,由于小样本尺寸小,这是不确定的。患者的疾病逐渐恶化,随后,他从潜在的晚期前期转移性疾病中的心脏和呼吸衰竭死亡。来自rcc的心脏转移是罕见的,并且具有各种介绍。将rcc往往抗化疗和放射疗法。全身疗法(免疫疗法,分子靶向剂)和?手术可能在这些患者中具有作用,具体取决于疾病和受累遗址的程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号